Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer

por Rosenberg, R, Hoos, A, Mueller, J, Nekarda, H
Publicado 2000

Toward the harmonization of immune monitoring in clinical trials: Quo vadis?

por Britten, C. M., Janetzki, S., van der Burg, S. H., Gouttefangeas, C., Hoos, A.
Publicado 2007

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

por Beusterien, K M, Szabo, S M, Kotapati, S, Mukherjee, J, Hoos, A, Hersey, P, Middleton, M R, Levy, A R
Publicado 2009

Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells

por Janetzki, Sylvia, Price, L., Britten, C. M., van der Burg, S. H., Caterini, J., Currier, J. R., Ferrari, G., Gouttefangeas, C., Hayes, P., Kaempgen, E., Lennerz, V., Nihlmark, K., Souza, V., Hoos, A.
Publicado 2009

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

por Britten, C. M., Janetzki, S., van der Burg, S. H., Huber, C., Kalos, M., Levitsky, H. I., Maecker, H. T., Melief, C. J. M., O’Donnell-Tormey, J., Odunsi, K., Old, L. J., Pawelec, G., Roep, B. O., Romero, P., Hoos, A., Davis, M. M.
Publicado 2010

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

por Eichler, H‐G, Baird, LG, Barker, R, Bloechl‐Daum, B, Børlum‐Kristensen, F, Brown, J, Chua, R, Del Signore, S, Dugan, U, Ferguson, J, Garner, S, Goettsch, W, Haigh, J, Honig, P, Hoos, A, Huckle, P, Kondo, T, Le Cam, Y, Leufkens, H, Lim, R, Longson, C, Lumpkin, M, Maraganore, J, O'Rourke, B, Oye, K, Pezalla, E, Pignatti, F, Raine, J, Rasi, G, Salmonson, T, Samaha, D, Schneeweiss, S, Siviero, PD, Skinner, M, Teagarden, JR, Tominaga, T, Trusheim, MR, Tunis, S, Unger, TF, Vamvakas, S, Hirsch, G
Publicado 2015